My watch list
my.bionity.com  
Login  

Perverse effects of vaccination



The perverse effects of vaccination require two conditions:

  1. Too few susceptibles are vaccinated against an infectious disease.
  2. The severity of the disease increases with age.

When too few are vaccinated the disease spreads more slowly than in an unvaccinated population. This raises the average age of infection, increasing the number of serious health problems associated with the disease.

Contents

Definition

There is a critical threshold value (denoted qc) at which enough people are immune to the disease that its spread through the population (even to unvaccinated susceptible individuals) is stopped. This effect is commonly known as herd immunity.

If a vaccination programme does not attain qc, its effect is not to prevent the spread of the disease across the unvaccinated population; instead it delays the spread and so increases the average age at which individuals are infected. In some diseases that have an increased severity or risk of complications with increased age, therefore, such a vaccination programme may actually increase the number of deaths from and/or problems relating to the disease. Some epidemiologists also refer to this as an "epidemiological shift". These are the perverse effects.[1]

Examples

  • A rise in congenital rubella syndrome (CRS) cases in Greece following the introduction in 1975 of rubella vaccination for young children.[2] This vaccination program failed because it did not attempt to protect adolescents and young women, and did not attempt to obtain high coverage, and shows that rubella vaccination programs should not be halfhearted.[3]
  • A similar claim has been made for CRS the United States in the early 1970s,[4] but this misrepresents the overall pattern of CRS incidence, which has fallen from an estimated 20,000 in the 1964 epidemic to 7 in 1983,[3] with a large drop in CRS incidence the early 1980s[5] and with rubella eliminated in the U.S. by 2004.[6]

Diseases

Some infectious diseases that increase in severity with age:

See also

References

  1. ^ Anderson RM, May RM (1991). Infectious Diseases of Humans: Dynamics and Control. Oxford Univ. Press. ISBN 0-19-854040-X. 
  2. ^ Panagiotopoulos T, Antoniadou I, Valassi-Adam E (1999). "Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review". BMJ 319 (7223): 1462–7. PMID 10582926.
  3. ^ a b King S (1999). "Vaccination policies: individual rights v community health. We can't afford to be half hearted about vaccination programmes". BMJ 319 (7223): 1448–9. PMID 10582910.
  4. ^ Diodati C (1999). Immunization: History, Ethics, Law and Health. Integral Aspects. ISBN 0-9685080-0-6. 
  5. ^ Cochi SL, Edmonds LE, Dyer K et al. (1989). "Congenital rubella syndrome in the United States, 1970–1985. On the verge of elimination". Am J Epidemiol 129 (2): 349–61. PMID 2912045.
  6. ^ Meissner HC, Reef SE, Cochi S (2006). "Elimination of rubella from the United States: a milestone on the road to global elimination". Pediatrics 117 (3): 933–5. doi:10.1542/peds.2005-1760. PMID 16510677.
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Perverse_effects_of_vaccination". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE